Representatives from the Southern Association of Colleges and Schools Commission on Colleges will make an on-site visit as part of the process of reaffirming UAB’s accreditation. SACSCOC requires all institutions to undergo an accreditation reaffirmation every 10 years.

The walking track at UAB's Rec Center will be open from 11 a.m. to 1 p.m. for employees who want to take a break from their desk and get their steps in.

We’re looking for adults with ASCVD or high risk for ASCVD to join the V-INCLUSION Study, evaluating a new FDA-approved cholesterol-lowering injection called Inclisiran.

You may qualify if you:

✔️ Have a history of heart attack, stroke, TIA, or peripheral artery disease
✔️ Are currently taking a statin or have statin intolerance
✔️ Have high LDL-C (bad cholesterol)
✔️ Identify as female, live in a rural area, or are from an underrepresented racial or ethnic group

What’s in it for you?

✅ Free access to Inclisiran for at least one year
✅ Compensation provided for participation
✅ Extra monitoring and heart health screening in addition to your usual care
✅ Advance research that may improve heart health in underserved communities

Half of participants will receive Inclisiran during Year 1, the other half in Year 2.

Your participation may help shape better cardiovascular care for future generations.

Spots are limited. Contact us today to see if you’re eligible!

Contact us at: 205-934-5217

Three hundred employees with 20 or more years of service will be honored during a reception April 8. John F. Kearney, Ph.D., will be honored for 50 years of service to UAB.

We are unlocking new gateways to treating depression and we are looking for volunteers to participate in a clinical trial.

Who's eligible for the study?

If you have been diagnosed with depression.
If you are between the ages of 18-64
If you are currently experiencing a major depressive episode that has lasted at least 3 weeks but not longer than 18 months.

If you are otherwise healthy and have not been diagnosed with other medically important conditions or psychiatric conditions such as bipolar disorder (BP), antisocial personality disorder (ASPD), obsessive compulsive disorder (OCD), borderline personality disorder (BPD) or attention-deficit/hyperactivity disorder (ADHD) or major diseases, have not had electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), deep brain stimulation or repetitive transcranial magnetic stimulation (TMS) within 5 years or have failed to respond to ECT at any time, This STUDY Might Be For You!

For more information, contact Dana Green at danagreen@uabmc.edu or 205-975-6426.

Kathy Nugent, Ph.D., executive director of the UAB Harbert Institute for Innovation and Entrepreneurship, will lead efforts to advance and align biotechnology research, innovation and commercialization, driving economic development and job creation in Birmingham and across Alabama. 

Join a clinical research study that seeks to improve the lives of those suffering from depression. We are looking for volunteers to participate in a clinical trial.

Are you eligible to enroll in the Amplify Study?

• Must be between 18 and 65 years of age and meet the DSM-5 criteria for a diagnosis of MDD.
• You are experiencing a moderate or severe major depressive episode of up to 12 months.
• You have been using a SSRI or SNRI antidepressant for at least 6 weeks and are having an inadequate response.
• You do not have a history of obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), panic disorder, or eating disorder, according to DSM-5 criteria.

For more information, contact Dana Green at (205) 975-6426 or danagreen@uabmc.edu or Candace Green at (205) 975-0068 or candacegreen@uabmc.edu.

You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples.

Participants will be compensated $675 for completing all the visits.

To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.

Look back at some of our photographers' favorite images from February 2025 in this slideshow.

The UAB SUCCESS Initiative honors Eric Ford, Ph.D., professor in the School of Public Health and chair of the UAB Faculty Senate, for going above and beyond in shaping the student experience at UAB. Champions will be selected quarterly by the initiative’s executive steering committee.